Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers
In Brief: Garb Raps “Hostility Of Executive Branch”; Hew Considers Allowing Grants For Industry
New Mexico CBCCP Charges Contracts Terminated for “Mundane Political, Economic” Factors
“Dog And Pony Show” At FCRF For NCAB OFF
Congress Asked To Equalize Cuts, Add $20 million For Centers
ACS Says New Tax Policy Hurts Charity Funds
Study Finds Short Term Tests Predict Carcinogenicity
Trending Stories
- Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Caught in the crossfire: The critical threats facing cancer centers, research, and patient care
- Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated
